Inventor

LOREN D. WALENSKY

Inventor
US

Overview

20→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
C07DHeterocyclic compounds4%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds3%
C12YEnzymes3%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
12,570,698Stabilized peptides for covalent binding to target protein202612,534,501Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9202612,528,846BH4 stabilized peptides and uses thereof202612,466,853Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides202512,441,775BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss202512,391,733Stapled intracellular-targeting antimicrobial peptides to treat infection202512,387,815Visual representations of peptide sequences202512,366,576Compositions, assays, and methods for direct modulation of fatty acid metabolism202512,358,960Selective targeting of ubiquitin- and ubiquitin-like E1-activating enzymes by structurally-stabilized peptides202512,344,643Compositions and methods for inhibition of FOXP3202512,153,051Reagents for quantitative mass spectrometry202411,982,674Reagents for quantitative mass spectrometry202411,952,432Cell-permeable stapled peptide modules for cellular delivery202411,945,846Stapled intracellular-targeting antimicrobial peptides to treat infection202411,834,520Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides202311,567,082Compositions, assays, and methods for direct modulation of fatty acid metabolism202311,466,064Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss202211,358,960Pyrazol-3-ones that activate pro-apoptotic BAX202211,325,955Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections202211,220,532Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-92022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to DANA FARBER CANCER INST INC (20)· patent assignee history
2022–2025Patents assigned to HARVARD COLLEGE (4)· patent assignee history
2022–2026Based in US· patent location history
2025Patents assigned to UNIV CHICAGO (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DANA FARBER CANCER INST INC202022–2026
HARVARD COLLEGE42022–2025
UNIV CHICAGO12025
Locations
LocationPatentsSpan
US202022–2026